naringenin has been researched along with Autism Spectrum Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhandari, R; Kuhad, A; Paliwal, JK | 1 |
| Gai, J; Lei, J; Tang, J; Wang, Y; Xing, J; Zhang, C; Zhang, J | 1 |
2 other study(ies) available for naringenin and Autism Spectrum Disorder
| Article | Year |
|---|---|
Enhanced Bioavailability and Higher Uptake of Brain-Targeted Surface Engineered Delivery System of Naringenin developed as a Therapeutic for Autism Spectrum Disorder.
Topics: ATP Binding Cassette Transporter, Subfamily B; Autism Spectrum Disorder; Biological Availability; Brain; Drug Carriers; Glycols; Humans; Nanoparticles; Neuroinflammatory Diseases; Particle Size; Spectroscopy, Fourier Transform Infrared | 2023 |
Exploration of potential targets and mechanisms of Naringenin in treating autism spectrum disorder via network pharmacology and molecular docking.
Topics: Autism Spectrum Disorder; Drugs, Chinese Herbal; Humans; Molecular Docking Simulation; Network Pharmacology | 2022 |